Worth reading
72In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1116000
¥Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of the 24th Stock Acquisition Rights with Exercise Price Adjustment Clauses by Third-Party Allotment
Who receives how much
55,800,000 potential shares (558,000 stock acquisition rights, with each stock acquisition right representing 100 common shares)
Name: EVO FUND; 558,000 stock acquisition rights
The lower thin line represents the existing number of shares to which these shares will be added.
¥2 per stock acquisition right
Total issue value
¥1,116,000
Amount of funds to be raised
¥1,154,916,000 (Note: the actual amount raised may vary depending on the exercise price and other factors.)
Terms of the stock acquisition rights
Exercise price
Initial exercise price: ¥21. From the second trading day after the allotment date, in principle, the exercise price will be adjusted on each trading day to 100% of the lowest closing price during the price calculation period. Floor exercise price: ¥11. In the event of exercise in excess of the limit, the exercise price will be adjusted so that it does not fall below the closing price on the date of the issuance resolution.
Exercise period
From 12 November 2026 to 12 December 2028
Number of Stock Acquisition Rights
Total issued: 558,000 stock acquisition rights. Unexercised balance: Not disclosed.
Payment date
11 November 2026
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of the 24th Stock Acquisition Rights with Exercise Price Adjustment Clauses by Third-Party Allotment |
| Number of shares to be issued or disposed of | 55,800,000 potential shares (558,000 stock acquisition rights, with each stock acquisition right representing 100 common shares) |
| Issue price and disposal price | ¥2 per stock acquisition right |
| Total issue value | ¥1,116,000 |
| Amount of funds to be raised | ¥1,154,916,000 (Note: the actual amount raised may vary depending on the exercise price and other factors.) |
| Payment date | 11 November 2026 |
| Intended allottee | Name: EVO FUND; 558,000 stock acquisition rights |
| Exercise price | Initial exercise price: ¥21. From the second trading day after the allotment date, in principle, the exercise price will be adjusted on each trading day to 100% of the lowest closing price during the price calculation period. Floor exercise price: ¥11. In the event of exercise in excess of the limit, the exercise price will be adjusted so that it does not fall below the closing price on the date of the issuance resolution. |
| Exercise period | From 12 November 2026 to 12 December 2028 |
| Number of Stock Acquisition Rights | Total issued: 558,000 stock acquisition rights. Unexercised balance: Not disclosed. |
Items this document does not state (18)
Estimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because payment of the total issue price for the 24th Stock Acquisition Rights under the Board of Directors' resolution dated 26 October 2026 has been completed.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.